Our findings revealed a total of 35 CpG methylation sites within the GCN1 region (Figures 6A, B), with significantly reduced MFSD12 methylation levels observed in tumor tissue samples compared to normal tissues (Figure 6C). The gene discussed is MFSD12; the disease is neoplasm.